Standard of practice in cardiology for pharmacy services

Standard of practice in cardiology for pharmacy services Joanna Pizzi, BPharm, GradCertPharmPrac, MClinPharm(Research), MSHP*, Adam Livori, BAppSci(NucMed), BPharm(Hons), GradCertPharmPrac, MSHP, Cia Connell, BPharm(Hons), GradCertPharmPrac, MClinPharm, MSHP, Adam Hort, BPharm GradDipClinPharm, GAICD, FSHP, Adaire Prosser, BPharm(Hons), BPharmSci, AdvPP(I), MSHP, Catherine Zhang, BPharm, GradDipClinPharm, MSHP, Kate Ziser, BPharm, GradDipEd, AdvPP(II), GradCertPharmPrac, MSHP, Courtney Munro, BPharm, GradCertPharmPrac, MPharmPrac, AACPA, PhD, FSHP, Yee Mellor, BPharm, MCncrSc, GPhC, MSHP 1 Cardiology Leadership Committee, The Society of Hospital Pharmacists of Australia, Collingwood, Australia 2 Alfred Health, Melbourne, Australia 3 Monash University, Melbourne, Australia 4 Ballarat Health Services, Ballarat, Australia 5 Fiona Stanley Hospital, Murdoch, Australia 6 SA Pharmacy, Flinders Medical Centre, Flinders, Australia 7 Gold Coast University Hospital, Southport, Australia 8 Princess Alexandra Hospital, Brisbane, Australia 9 The Society of Hospital Pharmacists of Australia, Collingwood, Australia

[1]  Lisa G. Pont,et al.  Attitudes, barriers and facilitators of hospital pharmacists conducting practice‐based research: a systematic review , 2021, Journal of Pharmacy Practice and Research.

[2]  D. Kong,et al.  Towards OPtimising Care of Regionally-Based Cardiac Patients With a Telehealth Cardiology Pharmacist Alinic (TOPCare Cardiology). , 2021, Heart, lung & circulation.

[3]  A. Ralph,et al.  The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease , 2020, The Medical journal of Australia.

[4]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[5]  C. Baigent,et al.  European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. , 2020, European heart journal. Quality of care & clinical outcomes.

[6]  R. Zecchin,et al.  Cardiac Rehabilitation Quality in Australia: Proposed National Indicators for Field-Testing. , 2020, Heart, lung & circulation.

[7]  L. Pont,et al.  Standard of practice in geriatric medicine for pharmacy services , 2020 .

[8]  G. Birdsey,et al.  714 Adherence to Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention , 2020 .

[9]  S. Kirsa,et al.  Multi‐site evaluation of partnered pharmacist medication charting and in‐hospital length of stay , 2020, British journal of clinical pharmacology.

[10]  P. Sanders,et al.  Home-Based Education and Learning Program for Atrial Fibrillation: Rationale and Design of the HELP-AF Study. , 2019, The Canadian journal of cardiology.

[11]  P. Macdonald,et al.  National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. , 2018, Heart, lung & circulation.

[12]  P. Sanders,et al.  National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. , 2018, Heart, lung & circulation.

[13]  Stefano Omboni,et al.  Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases , 2018, Open Heart.

[14]  G. Levine.  Chapter 17 – ST-Elevation Myocardial Infarction , 2018 .

[15]  Judy W. M. Cheng.  Current perspectives on the role of the pharmacist in heart failure management , 2018, Integrated pharmacy research & practice.

[16]  I. Scott,et al.  National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. , 2016, Heart, lung & circulation.

[17]  N. Burgess.  Society of Hospital Pharmacists of Australia, The , 2012 .

[18]  M. Shah,et al.  The outcomes of emergency pharmacist participation during acute myocardial infarction. , 2012, The Journal of emergency medicine.

[19]  B. Burnand,et al.  Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. , 2011, Archives of internal medicine.

[20]  F. McAlister,et al.  Pharmacist care of patients with heart failure: a systematic review of randomized trials. , 2008, Archives of internal medicine.

[21]  K. Galbraith,et al.  SHPA Standards of Practice for Clinical Pharmacy , 2005 .

[22]  L. Luddington,et al.  Success of a multidisciplinary heart failure clinic for initiation and up‐titration of key therapeutic agents , 2005, European Journal of Heart Failure.